Ephrin B2 Receptor and Microsatellite Status in Lymph Node-Positive Colon Cancer Survival
Open Access
- 1 October 2013
- journal article
- Published by Elsevier in Translational Oncology
- Vol. 6 (5) , 520-527
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant TherapyJNCI: Journal of the National Cancer Institute, 2011
- Cost-Effectiveness of Targeted Therapy With Cetuximab in Patients With K-ras Wild-Type Colorectal Cancer Presenting With Initially Unresectable Metastases Limited to the Liver in a German SettingClinical Therapeutics, 2011
- Serrated Polyps and Colorectal Cancer: New Pathway to MalignancyAnnual Review of Pathology: Mechanisms of Disease, 2009
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal CancerNew England Journal of Medicine, 2008
- Cetuximab for the Treatment of Colorectal CancerNew England Journal of Medicine, 2007
- EphB receptor activity suppresses colorectal cancer progressionNature, 2005
- Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?Journal of Clinical Oncology, 2004
- EphrinB Phosphorylation and Reverse SignalingMolecular Cell, 2002
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- A genetic model for colorectal tumorigenesisCell, 1990